About
Recognized leader with over 25 years' experience in biostatistics, clinical development, and personalized medicine. Instrumental in Oncotype Dx development and founder of multiple clinical diagnostics companies, with current focus on early detection technologies for breast, prostate, lung, and colon cancer.
Experience
- Optina DiagnosticsAdvisorcurrent2025 — present
- DigitalDx VenturesEntrepreneur in Residencecurrent2024 — presentMenlo Park, California, United States
- CellMax LifeSr. VP Clinical Studies and Biostatisticscurrent2018 — presentSunnyvale, California
- Cellworks LifeChief Biostatistician and Clinical Studiescurrent2019 — presentSouth San Francisco, California, United States
- Valar LabsAdvisorcurrent2023 — present
- BioAIAdvisorcurrent2020 — present
- Multiple CompaniesBiostatistics and Clinical Developmentcurrent2016 — presentLos Altos, CA
- Delphi Diagnostics Inc.Advisor2023 — 2024
- Nephrosant, Inc.Founder2016 — 2019San Francisco Bay Area
- InvitaeBiostatistics & Clinical Studies2015 — 2016458 Brannan Street, San Francisco, CA 94107
- Genomic HealthSr. VP Biostatistics, Data Mgmt & Medical Operations2003 — 2015301 Penobscot Drive Redwood City, CA 94063-4700
- Novation BiosciencesFounder & CEO2001 — 2003Purchased by Agilent Technologies
- Incyte GenomicsGeneral Manager1997 — 2001Now Incyte Pharmaceuticals - 1801 Augustine Cut-off, Willmington, DE 19803
- Chiron CorporationAssociate Director Non-Clinical Statistics1994 — 1997Acquired by Novartis Pharmaceuticals
- Syntex PharmaceuticalsStatistician1988 — 1990Acquired by Roche Pharmaceuticals
Education
- UCLAPh.D., Biostatistics1984 — 1990
- Stanford UniversityMS, Computational Statistics1980 — 1984
- California State University - East BayBS, Statistics1977 — 1980
- Golden Gate UniversityMBA, Executive Business
- Granada High School1972 — 1976
Skills & more
Biostatistics26Genomics27Biotechnology20Bioinformatics12Statistics11Life Sciences17Clinical Trials7Pharmaceutical Industry6Lifesciences5Clinical Development7Oncology8Genetics4
+12 more
Molecular BiologyMedical DevicesRDrug DiscoveryData ManagementFDACancerData MiningqPCRInfectious DiseasesSASImmunologyFrom Drew's professional profile.
Colleagues at AOA Dx
Abby McElhinny
Chief Scientific Officer at AOA Dx
Alex Fisher
Chief Operating Officer & Co-Founder at AOA Dx
Anna Jeter
Chief Regulatory Officer & Co-Founder at AOA Dx
Cory Bystrom
Senior Director, Biomarker & Analytical Development at AOA Dx
Elizabeth Yarber
Senior Director of Clinical Operations at AOA Dx
Emily Chang
Director, R&D at AOA Dx
James White
Scientific Advisor at AOA Dx
John Friedman
Board Member at AOA Dx